Kingenic Launches Qllerk Allergy Relief in India.
Kingenic Lifescience Pvt. Ltd. (India),is a research-led, integrated global pharmaceutical company, today announced that it has launched Qllerk-LM Allergy Relief (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film-coated tablets in Indian market, as a prescription product for the treatment of seasonal and perennial allergic rhinitis in patients above 15 years of age. Combination aids relief from sneezing and runny nose due to allergic skin condition and reduces airway inflammation.
" India is one of the key markets for us and we are consistently looking to expand our product portfolio consistently. We believe that the launch of Qllerk-LM will help enhance and expand our presence in this segment." said, Manan Kinariwala, Founder & CEO - Kingenic Lifescience Pvt. Ltd. (India)